Chris Lipinski discusses life and chemistry after the Rule of Five.
By Christopher A. Lipinski. 2003
69 citations recorded by the source corpus.
Subfields: Computational Chemistry & Drug Discovery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Chemistry & Drug Discovery
- C. K. Surratt
- Gerhard Klebe
- Chi‐Yuan Wu
- Jeffry D. Madura
- L. Benet
- Michael J. Wasko
- Kendy A. Pellegrene
Citations in the corpus
- A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets (2015, background): “Still, Christopher Lipinski has stated that Pfizer would not pursue compounds that broke two of the five parameters (19).”
- Virtual ligand screening: strategies, perspectives and limitations (2006, background): “Unlike the professed opinion that in docking the geometry problem has been resolved to a sufficient extent, and that the scoring problem remains an open question [120,121], it appears that both are intimately related.”
- Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System (2004, background): “Lipinski has noted that the Rule of 5 was intended as a very crude filter (24).”